Novan Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- March 27, 2015
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $50,000,000
Company Info
- Founders
- Nathan Stasko
- Company Description
- Novan is a privately-held, clinical stage biotechnology company advancing potentially best-in-class therapies using drugable nitric oxide. The company's patented Nitricil™ technology overcomes the previous delivery issues with nitric oxide by stably storing the gaseous species as a solid that can be transformed into targeted therapeutics.
- Market
- Clinical stage therapies for skin diseases
- Location
- Durham, North Carolina, USA
- Coinvestors
- Malin Corporation